Trial intelligence / Profile preview

Topical morphine gel for pain reduction in malignant cancer wounds

RBR-3rqcxqdPhase 2Not yet recruiting

Sponsor
Escola de Enfermagem Aurora de Afonso Costa
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Fungating tumor comparing Topical morphine hydrogel with Lidocaine gel control (2 arms). Planned start Nov 2022; status: not yet recruiting.

02

Drugs

morphinelidocaine
03

Conditions

Fungating tumor

Beyond the preview

Go deeper on RBR-3rqcxqd.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3rqcxqd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call